China Biotech Services Holdings Limited
8037.HKHKSEHealthcareMedical - Diagnostics & Research
Latest quote
HK$0.62
HK$0.00 · 0.00%
8037.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteEstablished in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- HK
- CEO
- Xiaolin Liu
- Listed since
- Jun 17, 2004
- Employees
- 135
Market position
52-week range
Current HK$0.62
- Open
- HK$0.62
- Previous close
- HK$0.62
- Volume
- 20K
- 0.05× average
- Average volume
- 391.71K
- Average daily volume
- Market cap
- 604.95M HKD
- Beta
- -0.66
- Market reference 1
- 50-day average
- HK$0.5934
- +4.48% above average
- 200-day average
- HK$0.7059
- -12.16% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.15B HKD
- P/E (TTM)
- -8.81×
- P/B (TTM)
- 3.16×
- P/S (TTM)
- 8.23×
- EV / EBITDA
- -19.34×
- Earnings yield
- -8.92%
- Free cash flow yield
- -25.50%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 10.51%
- Operating margin
- -103.24%
- Net margin
- -93.57%
- Return on equity
- -35.93%
- Return on assets
- -9.79%
- Return on invested capital
- -12.56%
Financial health
- Debt / equity
- 2.06×
- Current ratio
- 0.23×
- Altman Z-score
- -1.24
- Piotroski F-score
- 2 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 73.5M HKD | 70.51M HKD | 211.99M HKD | 1.85B HKD | 623.76M HKD |
| Cost of goods sold | 65.78M HKD | 75.45M HKD | 177.66M HKD | 750.58M HKD | 265.74M HKD |
| Gross profit | 7.73M HKD | −4.94M HKD | 34.32M HKD | 1.1B HKD | 358.02M HKD |
| Research and development | 17.2M HKD | 33.31M HKD | 29.04M HKD | 27.76M HKD | 28.68M HKD |
| Selling, general, and administrative | 66.44M HKD | 143.22M HKD | 152.95M HKD | 254.88M HKD | 168.81M HKD |
| Operating expenses | 83.61M HKD | 138.11M HKD | 162M HKD | 249.25M HKD | 168.81M HKD |
| Interest income | 8K HKD | 464K HKD | 3.74M HKD | 153K HKD | 12K HKD |
| Interest expense | 19.47M HKD | 16.92M HKD | 5.31M HKD | 3.5M HKD | 6.54M HKD |
| Depreciation and amortization | 16.44M HKD | 44.7M HKD | 55.58M HKD | 66.4M HKD | 68.11M HKD |
| Operating income | −75.89M HKD | −143.05M HKD | −127.67M HKD | 851.71M HKD | 189.44M HKD |
| Net income | −68.78M HKD | −198.15M HKD | −95.45M HKD | 258.09M HKD | 19.39M HKD |
Company facts updated Aug 25, 2026.
Earnings
- Latest EPS result
- -0.06
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.01
2023 complete year-97.5% since 2004
HK$0.3951
2,004
HK$0.01
2,023
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | May 19, 2023 | HK$0.01Special | May 22, 2023 | Jun 15, 2023 |
Dividend | Aug 19, 2004 | HK$0.0079Special | Aug 23, 2004 | Sep 30, 2004 |
Ex-dividend May 19, 2023
HK$0.01
Special
Record May 22, 2023 · Payment Jun 15, 2023
Ex-dividend Aug 19, 2004
HK$0.0079
Special
Record Aug 23, 2004 · Payment Sep 30, 2004
8037.HK peers
Continue in GoAI
Research 8037.HKresearch.disclaimer